Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Nitrous Oxide for Labor Makes US Comeback

By HospiMedica International staff writers
Posted on 23 Feb 2015
Long used for its anxiolytic properties during labor in European countries and Canada, nitrous oxide (N2O) use is resurging in the United States.

While in countries such as Norway, New Zealand, Sweden, Australia, and England, usage rates of inhalational N2O during parturition reach 70%, it has only recently become an option in the United States, following US Food and Drug Administration (FDA, Silver Spring, MD, USA) approval of new equipment for delivery room use in 2011. More...
So far, 38 hospitals and approximately 28 birth centers in the United States are already offering or working on plans to implement N2O as an analgesic option, according to Michelle Collins, PhD, CNM, of Vanderbilt University School of Nursing (Nashville, TN, USA).

When used for analgesia during labor, N2O is blended at a 50/50 blend with oxygen. The woman controls intake of the gas with her respiratory efforts by inhaling through a mask containing a demand valve that releases the gas only when she inhales; it may be used throughout all stages of labor. Alternatively, N2O may be initiated for second stage pushing or laceration repair after an unmedicated birth; for bedside procedures such as insertion of an intracervical foley bulb or intravenous (IV) line; during manual removal of the placenta; or during placement of an epidural catheter.

“The anxiolytic effect may be of significant use to laboring women, particularly in the transition stage of labor when self-doubt, trepidation over one's ability to complete the birth, and decreased ability to cope can occur,” wrote Dr. Collins, in a study published on January 19, 2015, in the Journal of Obstetric, Gynecologic, & Neonatal Nursing. “Women particularly at risk to be affected by anxiety and fear in labor include adolescents, women with histories of trauma, or those from other cultures who face giving birth in unfamiliar cultures.”

The exact mechanism of how analgesia or anesthesia from N2O is obtained is not fully understood. The prevailing theory is that it inhibits excitatory glutamatergic neurotransmission via inhibition of the N-Methyl-D-aspartic acid (NMDA) subtype of glutamate receptors. Another theory suggests that it stimulates endogenous opioid peptide release in the brain stem, which then stimulates the descending noradrenergic inhibitory neurons, moderating the processing of pain impulses in the spinal cord.

Related Links:

US Food and Drug Administration
Vanderbilt University School of Nursing



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.